🔎 Trials Near Me

Home › Atopic Dermatitis (Eczema) › Arkansas › Little Rock

Atopic Dermatitis (Eczema) clinical trials in Little Rock, AR

5 studies for Atopic Dermatitis (Eczema) are looking for participants at sites in and around Little Rock (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

RecruitingPhase 3
  • Arkansas Research Trials, North Little Rock · 2 mi away
Ages 2 to 11 · All sexes · Updated Sep 25, 2026 · NCT06807281

A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

RecruitingPhase 2
  • Dermatology Trial Associates, Inc, Bryant · 15 mi away
Ages 18 to 65 · All sexes · Updated Aug 28, 2026 · NCT07599813

A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis

RecruitingPhase 3
  • Applied Research Center and Wellness Clinic /ID# 268547, Little Rock
Ages 2 to 11 · All sexes · Updated Aug 6, 2026 · NCT06461897

A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

RecruitingPhase 3
  • Leo Pharma Investigational site, North Little Rock · 2 mi away
6 Months – 11 Years · All sexes · Updated Jul 7, 2026 · NCT06311682

A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Single and Multiple Dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis

RecruitingPhase 1
  • Arkansas Research Trials, North Little Rock · 2 mi away
Ages 18 and older · All sexes · Updated Sep 19, 2025 · NCT06055361

Atopic Dermatitis (Eczema) trials in other cities

Other studies in Little Rock

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.